DOCSLIB.ORG

Handbook of Experimental Pharmacology Volume 1041

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Handbook of Experimental Pharmacology Volume 1041 Handbook of Experimental Pharmacology Volume 1041/ Editorial Board G.V.R. Born, London P. Cuatrecasas, Ann Arbor, MI H. Herken. Berlin Opioids I Contributors H. Akil, S. Archer, A. Beaumont, M. Blum, D. Bronstein, S.R. Childers A.D. Corbett, B.M. Cox, V. Dauge, R. Day, S. Dermer, J. Donnerer A.W. Duggan, R. Elde, S.M. Fleetwood-Walker, L.D. Fricker M.-C. Fournie-Zaluski, T.L. Gioannini, A. Goldstein, T. H6kfelt V. H6llt, J.W. Holaday, H. Khachaturian, N. Kley, C.M. Knapp H.W. Kosteriitz, N.M. Lee, F.M. Leslie, N. Levin, M.E. Lewis J.P. Loeffler, H.H. Loh, D. Lorang, J.R. Lundblad, A. Mansour A.H. Mulder, R.A. North, S.J. Paterson, D.E. Pellegrini-Giampietro J.E. Pintar, F. Porreca, P.S. Portoghese, J.L. Roberts, B.R. Roques J. Rossier, R.B. Rothman, M.K.H. Schafer, P.W. Schiller A.N.M. Schoffelmeer, R.E.M. Scott, E.J. Simon, A.P. Smith J.A.M. Smith, S. Spector, A. Tempel, H. Teschemacher, K.A. Trujillo E. Young, S.J. Watson, P.L. Wood, R.S. Zukin Editor: Albert Herz Section Editors: H. Akil and E.1. Simon Springer-Verlag Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest Professor Dr.med. ALBERT HERZ Max-Planck-Institut fur Psychiatrie Abteilung Neuropharmakologie Am Klopferspitz 18 W-8033 Martinsried, FRG Section Editors Dr. med. HUDA AKIL Mental Health Research Institute School of Medicine University of Michigan 205 Zina Pitcher Ann Arbor, MI 48109, USA Dr. med. ERIC J. SIMON New York University Medical Center School of Medicine 550 First A venue New York, NY 10016, USA With 74 Figures and 52 Tables ISBN -13: 978-3-642-77462-1 e- ISBN -13: 978-3-642-77460-7 DOl: 10.1007/978-3-642-77460-7 Library of Congress Cataloging-in-Publication Data. Opioids I / contributors, H. Akil ... [et al.l; editor, Albert Herz; (H. Akil and EJ. Simon, section editors). p. cm. - (Handbook of experimental pharmacology; v. 104) Includes bibliographical references and index. ISBN-13:978-3-{i42-77462-1 l. Opioids. 2. Opioids - Receptors. I. Akil, H. (Huda) II. Herz, Albert, 1921- . III. Simon, Eric 1. IV. Title: Opioids l. V. Series. [DNLM: 1. Endorphins. 2. Receptors, Endorphin. WI HA51L v. 104 / QU 68 0603] QP905.H3 vol. 104 [RM328] 615' .1 s - dc20 [615' .78] DNLMIDLC for Library of Congress 92-2325 CIP This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broad­ casting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the German Copyright Law. © Springer-Verlag Berlin Heidelberg 1993 Softcover reprint of the hardcover 1st edition 1993 The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names arc exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature. Typesetting: Best-set Typesetter Ltd., Hong Kong 27/3130 - 5 4 3 2 1 0 - Printed on acid-free paper List of Contributors AKIL, H., Mental Health Research Institute, School of Medicine, University of Michigan, 205 Zina Pitcher, Ann Arbor, MI 48109, USA ARCHER, S., Department of Chemistry, Cogswell Laboratory, Rensselaer Polytechnic Institute, Troy, NY 12180-3590, USA BEAUMONT, A., Departement de Chimie Organique, U 266 INSERM, UA 498 CNRS, UFR des Sciences Pharmaceutiques et Biologiques, 4, avenue de l'Observatoire, F-75006 Paris, France BLUM, M., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA BRONSTEIN, D., Laboratory of Molecular Integrative Neuroscience, National Institute of Environmental Health Sciences, Research Triangle, Park, NC 27709, USA CHILDERS, S.R., Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA CORBETT, A.D., Department of Biomedical Sciences, University of Aberdeen, Marischal College, Aberdeen AB9 lAS, Great Britain Cox, B.M., Department of Pharmacology, Uniformed Services University of the Health Sciences, 4301 lones Bridge Road, Bethesda, MD 20814- 4799, USA DAUGE, V., Departement de Chimie Organique, U 266 INSERM, UA 498 CNRS, UFR des Sciences Pharmaceutiques et Biologiques, 4, avenue de l'Observatoire, F-75006 Paris, France DAY, R., I.A. DeSeve Laboratory of Biochemical and Molecular Neuro­ endocrinology, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada H2W lR7 DERMER, S., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA VI List of Contributors DONNERER, J., Department of Experimental and Clinical Pharmacology, University of Graz, A-801O Graz, Austria DUGGAN, A.W., Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, Great Britain ELDE, R., University of Minnesota, Department of Cell Biology and Neuroanatomy, 321 Church Street SE, Minneapolis, MN 55455, USA FLEETWOOD-WALKER, S.M., Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, Great Britain FRICKER, L.D., Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA FOURNIE-ZALUSKI, M.-C., Departement de Chimie Organique, U 266 INSERM, UA 498 CNRS, UFR des Sciences Pharmaceutiques et Biologiques, 4, avenue de l'Observatoire, F-75006 Paris, France GIOANNINI, T.L., Department of Psychiatry, New York University Medical Center, 550 First Avenue, New York, NY 10016, and Baruch College, CUNY, New York, NY 10010, USA GOLDSTEIN, AVRAM, Stanford University, 735 Dolores, Stanford, CA 94305, USA HOKFELT, T., Karolinska Institute, Department of Histology and Neuro­ biology, P.O. Box 60 400, S-104 01 Stockholm, Sweden HOLLT, V., Physiologisches Institut, Universitat Munchen, PettenkoferstraBe 12, W-8000 Munchen, FRG HOLADAY, J.W., Medicis Corporation, 100 East 42nd Street, 15th Floor, New York, NY 10017, USA KHACHATURIAN, H., Molecular and Cellular Neuroscience Research Branch, National Institute of Mental Health, Room llC-05, Parklawn Building, Rockville, MD 20857, USA KLEY, N., Molecular Neurooncology Laboratory, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, MA 02129-9142, USA KNAPP, C.M., Department of Pharmacy, Veterans Admin. Hospital, 130 W. Kingsbridge Road, Bronx, NY 10468, USA KOSTERLITZ, H.W., Unit for Research on Addictive Drugs, Marischal College, University of Aberdeen, Aberdeen AB9 lAS, Great Britain List of Contributors VII LEE, N.M., Department of Pharmacology, University of Minnesota Twin Cities, Medical School, 3-249 Millard Hall, 435 Delaware Street, S.E., Minneapolis, MN 55455, USA LESLIE, F.M., Department of Pharmacology, California College of Medicine, University of California, Irvine, CA 92717, USA LEVIN, N., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA LEWIS, M.E., Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA 19380, USA LOEFFLER, J.P., Laboratoire de Physiologie Generale, IPCB, 21, rue Rene Descartes, F-67100 Strasbourg Cedex, France LOH, H.H., Department of Pharmacology, University of Minnesota Twin Cities, Medical School, 3-249 Millard Hall, 435 Delaware Street, S.E., Minneapolis, MN 55455, USA LORANG, D., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA LUNDBLAD, J.R., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA MANSOUR, A., Mental Health Research Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI 48109-0720, USA MULDER, A.H., Department of Pharmacology, Free University Medical Faculty, Van der Boechorststraat 7, NL-1081 BT Amsterdam, The Netherlands NORTH, R.A., Vollum Institute, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA PATERSON, S.J., U.M.D.S., Guy's and St. Thomas's Medical and Dental School, Department of Pharmacology, Lambeth Palace Road, London SE1 7EH, Great Britain PELLEGRINI-GIAMPIETRO, D.E., Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461-1988, USA PINTAR, J.E., Department of Anatomy and Cell Biology, Columbia College of Physicians and Surgeons, 630 W. 168th Street, New York, NY 10032, USA VIII List of Contributors PORRECA, F., Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA PORTOGHESE, P.S., Department of Medicinal Chemistry, College of Phar­ macy, University of Minnesota, 308 Harvard Street, S.E., Minneapolis, MN 55455, USA ROBERTS, J.L., The Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA ROQuEs,
Load more

Recommended publications
  • The Discovery of the Opioid Peptides John Hughes
    THE DISCOVERY OF THE OPIOID PEPTIDES JOHN HUGHES Some time back I was interviewing Hannah Steinberg, and she said to me that she felt that one of the key discoveries was the discovery of enkephalin in the brain. This was brought to her in an unusual way when she went to try and get a copy of Nature to photocopy a copy of your article and found that the actual pages for that article had worn away - and this was only about 2 or 3 years after it had come out. Clearly it was a piece of work that caught the imagination not just for people within the field but of the wider public. Can I ask you how it all came about? Well like many of these things, scientific advances come about because, I guess, the individual scientists get fascinated by a particular problem. Why they get fascinated with that problem is often quite unclear. Okay some of the truly great may be want to understand the origin of life and so you have Watson and Crick and they went straight for it. The rest of us lesser mortals settle for what interests us, perhaps because of baggage we carry from the university, a particular lecture or a supervisor that really turned us on to a particular subject or particular area. Its difficult to say. I wanted to work in neuroscience. I knew that when then I completed my first degree but I also wanted to do medicine. I tried to combine both. I was at King's College Medical School for a while.
    [Show full text]
  • Pharmacology International No. 83 December 2014 the Semi-Annual Newsletter from the International Union of Basic and Clinical Pharmacology
    Pharmacology International No. 83 December 2014 The semi-annual newsletter from the International Union of Basic and Clinical Pharmacology In This Issue WCP2014 PharfA Pg. 9 Student Volunteer Pg. 13 Thank You Young Investigator Pg. 14 Competition Winners July 13 - 18, 2014 IOSP Satellite Meeting Pg. 16 IUPHAR Reports IOSP and ETRIS Pg. 19 Pharmacologists Enjoy Successful Teaching Resources th Education Section Pg. 21 17 World Congress of Basic and Clinical Pharmacology (WCP2014) Drug Metabolism and Pg. 25 in Cape Town, South Africa Drug Transporter Section Gastrointestinal Section Pg. 26 More than eight years have passed since the South African Society for Basic and Clinical Immunopharmacology Pg. 30 (ImmuPhar) Section Pharmacology won the bid in Beijing, China in 2006 to host this historic event in Cape Town. Geriatric Clinical Pg. 31 Including the satellite meetings in South Africa, the World Congress of Basic and Clinical Pharmacology Subcommittee Pharmacology (WCP2014) offered nearly three weeks of scientific activities in all areas of Pharmacoepidemiology & Pg. 32 basic and clinical aspects of medicines. It has been an amazing and successful journey. Pharmacovigilance Subcommittee Pediatric Clinical Pg. 33 Pharmacology Section The Congress Pharmacology from Cape Pg. 35 We were treated to a feast of more than 300 invited Town to Kyoto eminent scientists lecturing in more than 100 podium Latest News sessions in seven parallel tracks accompanied by Pr. Harmar Awarded J.R. Pg. 37 • Nobel Laureate Robert Lefkowitz (USA) as the Vane Medal Posthumously keynote opening address on G Protein Coupled GuideToPharmacology.org Pg. 38 Receptors (bottom left), New Release • Arthur Christopoulos (Australia) as the International Meet the 2014 - 2018 Pg.
    [Show full text]
  • Leslie L. Iversen
    Leslie L. Iversen BORN: Exeter, England October 31, 1937 EDUCATION: Cambridge University, B.A. (Biochemistry) (1961) Cambridge University, Ph.D. (Pharmacology) (1964) APPOINTMENTS: Postdoctoral Fellow, National Institutes of Health (1964–1965) Postdoctoral Fellow, Harvard Medical School (1965–1966) Research Fellow, Trinity College, Cambridge (1966–1967) Locke Research Fellow, Cambridge University (1967–1970) Director MRC Neurochemical Pharmacology Unit, Cambridge, (1970–1983) Director Neuroscience Research Centre, Merck Sharp & Dohme Ltd, Harlow, UK (1983–1995) Vice-President Neuroscience, Merck Research Labs (1986–1995) Visiting Professor of Pharmacology, Oxford University (1995–) Director, Wolfson Centre for Age Related Diseases, King’s College, London (1999–2004) HONORS AND AWARDS: Gaddum Lecturer, British Pharmacological Society (1971) F. O. Schmitt Lectureship, MIT, USA (1974) Associate of Neuroscience Research Program, MIT, USA (1975–1984) Fellow of the Royal Society, London (1980–) Honorary Member, American Academy of Arts and Sciences (1981–) Rennebohm Lecturer, University of Wisconsin, USA (1984) Ferrier Lecturer, Royal Society, London (1984) Foreign Associate Member, National Academy of Sciences USA (1986) Honoured Professor, Beijing Medical University, China (1988) Hans Kosterlitz Memorial Lecturer, British Physiological Soc (2000) Wellcome Gold Medal in Pharmacology, Brit. Pharm. Soc (2003) Lifetime Achievement Award, Brit. Assoc. Psychopharmacology (2006) Leslie Iversen has been at the forefront of research on neurotransmitters and neuropeptides and understanding the mode of action of CNS drugs. In his early work on catecholamines he was among the fi rst to describe the detailed properties and pharmacological specifi city of the noradrenaline transporter (NAT) in sympathetic nerves and brain, and he helped to strengthen the concept of antipsychotic drugs as dopamine receptor antagonists.
    [Show full text]
  • AN ORAL HISTORY of NEUROPSYCHOPHARMACOLOGY the FIRST FIFTY YEARS Peer Interviews
    AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Volume Three: Neuropharmacology Copyright © 2011 ACNP Thomas A. Ban (series editor) AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY Fridolin Sulser (volume editor) VOLUME 3: NEUROPHARMACOLOGY All rights reserved. No part of this book may be used or reproduced in any manner without written permission from the American College of Neuropsychopharmacology (ACNP). Library of Congress Cataloging-in-Publication Data Thomas A. Ban, Fridoln Sulser (eds): An Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews Includes bibliographical references and index ISBN: 1461161614 ISBN-13: 9781461161615 1. Neuropharmacology 2. Neurotransmitterr era 3. Mode of action of psychotropic drugs 4. Psychotropic drug development Publisher: ACNP ACNP Executive Office 5034A Thoroughbred Lane Brentwood, Tennessee 37027 U.S.A. Email: [email protected] Website: www.acnp.org Cover design by Jessie Blackwell; JBlackwell Design www.jblackwelldesign.com AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Edited by Thomas A. Ban Co-editors Volume 1: Starting Up - Edward Shorter Volume 2: Neurophysiology - Max Fink Volume 3: Neuropharmacology - Fridolin Sulser Volume 4: Psychoharmacology - Jerome Levine Volume 5: Neuropsychopharmacology - Samuel Gershon Volume 6: Addiction - Herbert D. Kleber Volume 7: Special Areas - Barry Blackwell Volume 8: Diverse Topics - Carl Salzman Volume 9: Update - Barry Blackwell Volume 10: History of the ACNP - Martin M. Katz VOLUME 3 NEUROPHARMACOLOGY ACNP 2011 VOLUME 3 Fridolin Sulser NEUROPHARMACOLOGY The Neurotransmitter Era in Neuropsychopharmacology Preface Thomas A. Ban Dedicated to the Memory of Bernard B. Brodie, President ACNP, 1965 PREFACE Thomas A. Ban In 1957 Ralph Gerard coined the term “psychotropic drugs” for chemicals which can control or induce mental pathology.1 Neuropharmacology studies the molecular substrate involved in the mode of action of these drugs.
    [Show full text]